FDA Issues Second Class 1 Recall in Two Weeks for Unauthorized COVID-19 Test
The FDA cited multiple reasons for issuing the warning and recall, including the fact that the test’s performance was not adequately established.
New Discovery Identifies How COVID-19 Overwhelms the Immune System, Potentially Providing New Targets for Testing and Treatments
What University of Southern California research showed about suppression of cells’ mitochondria in COVID-19 immune system response.